You guys are great! I'm sure I wouldn't get such great advice no matter how many services I belonged to...so I guess I won't be joining any time soon ;)...
Please remember that I am a stock novice but an itinerant gambler. I marvel at the folks that can look sideways at OGXI and see/not see a trading stock or a range bound biotech or a thinly traded commodity. All of that can be measured...but I don't think OGXI can. NO proven product, NO viable pipeline, NO recourse if statistical events are not achieved. This a gambler's folly with excellent management (please don't laugh too loudly because of their human foibles; they will likely serve to increase focus in an attempt to overcome their public exposure).
There is no butter-n-egg money or freshman emotion invested in this little mine shaft. SNUS syphoned 25% of my long-shot dollars and my OGXI shares showed up in my inbox for free (well, kind of). My intended ramp-up in OGXI shares is by no means house money...but it is a gambler's stake. The EXTREMELY low float and potential for markedly good news makes this stock much better than pot-odds in my book. I'd really like to watch the Russell index(es) and options volume, but I really don't yet have a knack for it (do gamblers really hedge with put/call options?).
I want ANS to succeed and I'd like to be there when it does. Darkout, the evidence for succeeding generations of ANS is mounting against your opinon/emotion but you still may yet be right...
AND THANKS FOR THE CONSIDERED ADVICE
Oh! One more thing...I'm about to increase my position in OGXI by 25% unless you guys and Summer talk me out of it. I will be gambling that volume will drive the price up before results are reported...I'll sell my new stake on a 20-25% runup.
Good luck (your comments are most welcome, lol)
Thanks for highlighting this resource which, for me, seems to be an excellent source for what's happening in the biotech/health research genre. Even though the video is from ASCO 2012 I have yet to see anything so well presented on OGX-427 and HSP27.